Northland Securities Comments on CVE:HIV FY2026 Earnings

HIVE Blockchain Technologies Ltd. (CVE:HIV) – Equities research analysts at Northland Securities lowered their FY2026 EPS estimates for HIVE Blockchain Technologies in a research note issued to investors on Tuesday, February 17th. Northland Securities analyst M. Grondahl now forecasts that the company will post earnings per share of ($0.76) for the year, down from their previous forecast of ($0.42). Northland Securities also issued estimates for HIVE Blockchain Technologies’ Q4 2026 earnings at ($0.30) EPS, Q1 2027 earnings at ($0.30) EPS, Q2 2027 earnings at ($0.29) EPS, Q3 2027 earnings at ($0.27) EPS, Q4 2027 earnings at ($0.20) EPS and FY2027 earnings at ($1.05) EPS.

Several other analysts also recently issued reports on HIV. Keefe, Bruyette & Woods downgraded HIVE Blockchain Technologies from a “moderate buy” rating to a “hold” rating in a research note on Tuesday, January 27th. B. Riley Financial raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Friday, November 21st. Two equities research analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Buy”.

HIVE Blockchain Technologies Stock Performance

HIVE Blockchain Technologies Ltd. is a business services company in the Business Services industry.